First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Stock Price Down 0.7% – Should You Sell?

Shares of First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) were down 0.7% during trading on Monday . The stock traded as low as $221.15 and last traded at $221.15. Approximately 21,871 shares changed hands during trading, a decline of 84% from the average daily volume of 139,583 shares. The stock had previously closed at $222.75.

First Trust NYSE Arca Biotechnology Index Fund Price Performance

The firm has a market capitalization of $2.52 billion, a price-to-earnings ratio of 21.72 and a beta of 0.68. The firm’s fifty day moving average is $209.61 and its 200 day moving average is $208.84.

Institutional Trading of First Trust NYSE Arca Biotechnology Index Fund

Institutional investors have recently made changes to their positions in the stock. High Point Wealth Management LLC acquired a new stake in shares of First Trust NYSE Arca Biotechnology Index Fund during the fourth quarter worth approximately $26,000. AG Campbell Advisory LLC bought a new position in First Trust NYSE Arca Biotechnology Index Fund during the fourth quarter valued at approximately $31,000. Russell Investments Group Ltd. raised its position in First Trust NYSE Arca Biotechnology Index Fund by 7,900.0% during the third quarter. Russell Investments Group Ltd. now owns 160 shares of the company’s stock valued at $29,000 after acquiring an additional 158 shares in the last quarter. Rossby Financial LCC raised its position in First Trust NYSE Arca Biotechnology Index Fund by 160.0% during the third quarter. Rossby Financial LCC now owns 169 shares of the company’s stock valued at $31,000 after acquiring an additional 104 shares in the last quarter. Finally, Cassaday & Co Wealth Management LLC bought a new position in First Trust NYSE Arca Biotechnology Index Fund during the first quarter valued at approximately $34,000.

About First Trust NYSE Arca Biotechnology Index Fund

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.